Cronos Group Inc. (TSX:CRON)

Canada flag Canada · Delayed Price · Currency is CAD
3.750
+0.040 (1.08%)
At close: Jan 13, 2026
32.51%
Market Cap1.44B
Revenue (ttm)184.36M
Net Income (ttm)50.28M
Shares Out382.89M
EPS (ttm)0.13
PE Ratio28.60
Forward PE38.27
Dividendn/a
Ex-Dividend Daten/a
Volume124,162
Average Volume400,550
Open3.710
Previous Close3.710
Day's Range3.710 - 3.770
52-Week Range2.270 - 4.660
Beta1.06
RSI50.99
Earnings DateFeb 27, 2026

About Cronos Group

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. The company is based in Stayner, Canada. [Read more]

Sector Healthcare
Founded 2012
Employees 459
Stock Exchange Toronto Stock Exchange
Ticker Symbol CRON
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

Marijuana industry taking fight against Wall Street blockades straight to Trump

Bankers have argued that Pot Inc.'s far-bigger prospective business – recreational use that would include the smoking of joints and ingesting high-inducing gummies – wasn't specifically addressed by t...

4 days ago - New York Post

Best Canadian Cannabis Stocks to Watch Entering 2026

The cannabis industry continues to evolve as investors look toward 2026 with renewed optimism. Canadian cannabis companies remain at the center of global expansion. They benefit from strong medical pr...

7 days ago - MarijuanaStocks

Cronos: A Standout Balance Sheet Among Its Peers

Cronos Group operates in a highly competitive industry but has a marked advantage over its peers owing to its vastly superior balance sheet. This superiority is a result of a 2019 investment by Altria...

14 days ago - Seeking Alpha

Trump Is Warming to Cannabis, but Investors Aren't Impressed

Stocks took a surprise tumble after the White House moved to reclassify marijuana as a less dangerous drug.

14 days ago - WSJ

2 Marijuana Stocks To Watch For Better Investing In 2026

The cannabis industry continues evolving into a bigger and more regulated global market. Legalization trends are expanding across the United States and international regions. This growth fuels long-te...

16 days ago - MarijuanaStocks

3 Marijuana Stocks To Watch In 2026

The cannabis industry is entering another critical growth phase, positioning 2026 as a potentially pivotal year. Particularly for long-term investors looking to make a profit with marijuana stocks. Af...

18 days ago - MarijuanaStocks

Marijuana Stocks To Watch After The Holidays

In 2026, the impact of cannabis rescheduling is expected to be far more visible in marijuana stock performance. Much more than in the initial announcement of cannabis becoming a Class 3 substance. Whi...

20 days ago - MarijuanaStocks

3 Top Marijuana Stocks After Cannabis Gets Rescheduled

Donald Trump's recent executive order moving cannabis off Schedule I marks a pivotal moment for the U.S. cannabis sector. While the order does not legalize marijuana at the federal level, rescheduling...

22 days ago - MarijuanaStocks

Inside the dealmaking that pushed Trump to reclassify pot, expand access

President Donald Trump's marijuana reclassification executive order followed a yearlong push by cannabis executives, billionaire allies and political operatives combining donations, lobbying and targe...

25 days ago - CNBC

After Trump's move to reclassify cannabis, here's what Wall Street is thinking

Analysts are now focused on the when the change will actually happen, as the cannabis industry waits for tax relief and expanded research opportunities.

25 days ago - Market Watch

Trump signs executive order to reschedule cannabis. Here's what's next

Trump's executive order shifts cannabis from Schedule I to Schedule III, and launches a Medicare pilot program for CBD products. Brandon Gomez unpacks what's next, the hurdles ahead and what shifted t...

25 days ago - CNBC Television

Trump just legalized marijuana nationwide — here's why potheads are rejoicing

As On The Money has been reporting since April, our famously drug-and-drink-averse president has been inching ever closer to making marijuana significantly less criminal in the eyes of the federal gov...

25 days ago - New York Post

Trump sparks market shock with MAJOR marijuana move

Rep. Greg Steube, R-Fla., joins ‘Mornings with Maria' to discuss cutting healthcare costs, the fight over Obamacare subsidies and shutdown risks, President Donald Trump's marijuana order and the GOP's...

25 days ago - Fox Business

Former WH drug policy advisor: Mass commercialization and promotion of marijuana isn't a good thing

Kevin Sabet, Smart Approaches to Marijuana CEO, former White House drug policy advisor and ‘One Nation Under Influence' author, joins 'Squawk Box' to discuss President Trump's executive order to recla...

25 days ago - CNBC Television

Why US banks are still wary of cannabis despite Trump's policy shift

President Donald Trump's move to relax federal marijuana regulations has been welcomed by the US cannabis industry, but it has not changed the sector's most persistent challenge. Access to mainstream ...

26 days ago - Invezz

How Trump's marijuana reclassification could impact medical research

Scotts Miracle-Gro CEO James Hagedorn discusses President Donald Trump signing an executive order to reclassify marijuana on ‘The Claman Countdown.' #fox #media #breakingnews #us #usa #new #news #brea...

26 days ago - Fox Business

Cannabis companies face hurdles accessing big banks despite reclassification, experts say

U.S. President Donald Trump's move to relax marijuana regulations could ease some burden for cannabis companies, but will likely keep doors to access capital from big banks closed, experts said.

26 days ago - Reuters

Trulieve CEO Kim Rivers reacts to marijuana being reclassified

Trulieve Founder, Chair, and CEO Kim Rivers joins 'Fast Money' with reaction to Pres. Trump reclassifying marijuana.

26 days ago - CNBC Television

Trump signed an executive order to reclassify marijuana.

About Yahoo Finance: Yahoo Finance provides free stock ticker data, up-to-date news, portfolio management resources, comprehensive market data, advanced tools, and more information to help you manage ...

26 days ago - Yahoo Finance

Trump signs order to expedite marijuana reschedules, Kevin Hassett vs. Kevin Warsh in Fed chair race

Market Domination Overtime anchor Josh Lipton breaks down the latest market moves for December 18, 2025. President Trump signed an executive order today to expedite the rescheduling of marijuana.

26 days ago - Yahoo Finance

Donald Trump Has Officially Reclassified Marijuana To A Schedule 3 Substance

It has officially happened, Donald J Trump has signed the executive order to reschedule cannabis. Now, cannabis has been taken from a Class 1 to a Class 3 substance under the Controlled Substances. At...

26 days ago - MarijuanaStocks

Trump signs executive order on marijuana reclassification; cannabis shares rally

President Donald Trump signed an executive order on Thursday directing federal agencies to reclassify marijuana from Schedule I to Schedule III. The move sent US cannabis stocks sharply higher on expe...

26 days ago - Invezz

President Trump signs executive order to reclassify marijuana, easing federal restrictions

President Trump signs an executive order to reclassify marijuana to a Schedule III classification, easing federal restrictions.

26 days ago - CNBC Television

Trump Signs Order Easing Federal Restrictions on Marijuana

President Donald Trump signs an executive order directing his administration to move cannabis into a less restrictive federal category. Sign up for the Washington Edition newsletter to find out how th...

26 days ago - Bloomberg Markets and Finance

Trump signs executive order easing federal restrictions on marijuana

Trump signed an executive order that will reclassify marijuana as a less harmful drug. The order is aimed at making it easier to research the drug.

26 days ago - Business Insider